YOUNG KWON - 25 Oct 2021 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Young Kwon, by Brian Lenz as Attorney-in-fact
Issuer symbol
ADMA
Transactions as of
25 Oct 2021
Net transactions value
+$100,000
Form type
4
Filing time
26 Oct 2021, 07:00:49 UTC
Previous filing
18 Oct 2021
Next filing
09 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Purchase $100,000 +100,000 +100% $1.00* 200,000 25 Oct 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a purchase from the underwriters in the October 2021 public offering of the issuer.